<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02755467</url>
  </required_header>
  <id_info>
    <org_study_id>C-16-EV08</org_study_id>
    <nct_id>NCT02755467</nct_id>
  </id_info>
  <brief_title>Clinical Evaluation of the Treatment of Spider Angioma</brief_title>
  <official_title>A Clinical Evaluation of the Treatment of Spider Angioma Using a Dual Wavelength Laser Emitting 532 nm Laser Energy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cutera Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cutera Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate the safety and effectiveness of the laser treatment for the treatment of spider
      angiomas.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this study is to evaluate the safety and efficacy of the 532 nm KTP laser
      within the Cutera Excel V system for the treatment of spider angiomas.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 26, 2016</start_date>
  <completion_date type="Actual">April 4, 2017</completion_date>
  <primary_completion_date type="Actual">January 13, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The investigator will perform a baseline assessment of the spider angiomas and compare the degree of improvement for each treated lesion at 4 weeks post-final treatment using the Physician's Global Assessment scale.</measure>
    <time_frame>Four weeks post laser treatment.</time_frame>
    <description>assessment of Baseline vs. 4 weeks post-final treatment for improvement of spider angiomas</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>At 4 weeks post-final treatment, subjects will be asked to rate their level of satisfaction with the laser treatment outcome and the overall laser treatment procedure, using the Subject Satisfaction Assessment Scale.</measure>
    <time_frame>Four weeks post laser treatment.</time_frame>
    <description>Subject satisfaction assessment of laser outcome and procedure at 4 weeks post-final treatment</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">21</enrollment>
  <condition>Spider Angioma</condition>
  <arm_group>
    <arm_group_label>Laser treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Each subject will receive a 532 nm KTP laser treatment for their spider angioma(s).</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>KTP laser</intervention_name>
    <description>Dual Wavelength Laser Emitting 532 nm Laser Energy</description>
    <arm_group_label>Laser treatment</arm_group_label>
    <other_name>Cutera Excel V</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Males or females, 5 to 65 years of age (inclusive).

          2. Fitzpatrick Skin Types I-IV

          3. Subject must be able to read, understand and sign the Informed Consent Form.

          4. If subject is a minor (&lt;18 years old in Illinois), Assent must be obtained from the
             subject and a Parental Consent Form must be signed by the parents or legal guardian.

          5. Subject must be willing and able to adhere to the treatment and follow-up schedule and
             post-treatment care instructions.

          6. Willing to have limited sun exposure for the duration of the study, including the
             follow-up period.

          7. Willingness to have digital photographs taken of their spider angioma(s) and agree to
             use of photographs for presentation, educational or marketing purposes

          8. Agree not to undergo any other procedure for the treatment of spider angioma during
             the study.

        Exclusion Criteria:

          1. Pregnant.

          2. History of pigmentary disorders, particularly tendency for hyper- or
             hypo-pigmentation.

          3. Having a known anti-coagulative condition or taking anticoagulation medications,
             including aspirin.

          4. History of seizure disorders due to light.

          5. Systemic use of isotretinoin (AccutaneÂ®) within 6 months of study participation.

          6. Excessively tanned in areas to be treated or unable/unlikely to refrain from tanning
             during the study.

          7. Participation in a study of another device or drug within 3 months prior to enrollment
             or during the study.

          8. In the opinion of the investigator, any physical or mental condition which might make
             it unsafe for the subject to participate in this study or which requires systemic
             therapy that could interfere with this research study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>5 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kelly Stankiewicz, MD FAAD</last_name>
    <role>Principal Investigator</role>
    <affiliation>DuPage Medical Group</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>DuPage Medical Group</name>
      <address>
        <city>Naperville</city>
        <state>Illinois</state>
        <zip>60563</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 25, 2016</study_first_submitted>
  <study_first_submitted_qc>April 28, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 29, 2016</study_first_posted>
  <last_update_submitted>September 12, 2017</last_update_submitted>
  <last_update_submitted_qc>September 12, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 14, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemangioma</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

